Cancer Institute (WIA) provides researchers with access to state-of-the-art infrastructure spanning core instrumentation, GMP manufacturing, clinical trials, biobanking, and preclinical disease modeling — enabling translational cancer research from bench to bedside.
Centralized instrumentation facility housing advanced sequencing, flow cytometry, microscopy, and molecular biology platforms for translational cancer research.
Learn more
Good Manufacturing Practice facility dedicated to producing cell-based therapies and immunotherapeutics under regulatory-compliant conditions.
Learn more
Dedicated infrastructure for clinical research across departments. We conduct clinical trials from Phase II to Phase IV.
Learn more
Centralized repository of annotated tumor tissues, blood samples, and biofluids supporting translational research across multiple cancer types.
Learn more
Preclinical modeling platform supporting in vitro and in vivo studies for drug efficacy testing and mechanistic cancer research.
Learn more
.png&w=96&q=75){kind=small}